Navigation Links
Genesis Biopharma Announces Letter to Shareholders Posted to Website
Date:8/30/2011

LOS ANGELES, Aug. 30, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC.BB: GNBP), a biotechnology company developing targeted cancer therapies, today announced that the following Letter to Shareholders will be posted today to the investor relations section of the Company's website at www.genesis-biopharma.com.  In addition, on August 22, 2011, the Company filed with the U.S. Securities and Exchange Commission its Quarterly Report for the three and six months ended June 30, 2011 on Form 10-Q. The Form 10-Q includes unaudited interim consolidated financial statements containing the information highlighted below, as well as additional information regarding the Company. The Form 10-Q is available at www.sec.gov or www.genesis-biopharma.com.

Dear Shareholders,

It is with great pleasure that I am providing this update on the progress Genesis Biopharma is making in developing autologous cell therapies for the treatment of various cancers.  Importantly, in the past few months we have built the foundation upon which we will advance our lead product opportunity, Contego™ for the treatment of metastatic melanoma.

Contego is based on the standard therapy currently being administered to Stage IV metastatic melanoma patients at the National Cancer Institute (NCI), MD Anderson Cancer Center and H. Lee Moffitt Cancer Center & Research Institute.  Previous studies conducted at the NCI and other major cancer centers have shown significantly higher Complete Response and Overall Response Rates using adoptive cell transfer-based immunotherapies (ACT) to treat metastatic melanoma in late stage patients. The published study can be accessed at '/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
2. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
3. Genesis Biopharma to Hold Business Update Conference Call on June 29
4. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
5. Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
6. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
7. CryoLife Announces Completion of Acquisition of Cardiogenesis
8. CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
10. Cardiogenesis Reports First Quarter 2011 Results
11. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
(Date:8/27/2015)... -- Biosimilars are not generics and the Biologics ... Drug Administration (FDA) for recognizing that each biosimilar ... issued today. The FDA,s draft guidance on nonproprietary ... for biological products to bear a nonproprietary name ... the agency,s thinking that "there is a need ...
(Date:8/27/2015)... According to a new market research report "Medical Lifting Sling ... Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End User (Home, ... Lifting Sling Market is poised to reach USD 706.0 Million by ... 11.4 % from 2015 to 2020. , Browse ... ables and 65 F igures spread ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... , SAN CLEMENTE, ... leading maker of clinically-proven natural remedies, today released a new ... their families. A tip sheet on "Selecting Safe and Effective ... Moms" series, is now available on the company,s website at ...
... , PRINCETON, N.J. , Feb. 8 ... will present at the 20th Annual Global Healthcare Services Conference on ... .  Investors may access a live webcast of the presentation at ... software, please log on 10 minutes early. , Covance, with headquarters ...
Cached Medicine Technology:Bionorica Offers Tips on Selecting Safe and Effective Natural Remedies for Children 2Bionorica Offers Tips on Selecting Safe and Effective Natural Remedies for Children 3Bionorica Offers Tips on Selecting Safe and Effective Natural Remedies for Children 4
(Date:8/29/2015)... ... August 30, 2015 , ... Electronic Informed Consent for ... 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic informed ... , Clinical trial sites can now use audio, video and interactivity to ...
(Date:8/29/2015)... PITTSBURGH, PA (PRWEB) , ... August 29, 2015 ... ... 1996," said one of two inventors from Miller Place, N.Y. "I specialize in ... pain and discomfort. In addition, it can be used for additional muscle dysfunction ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... ... 29, 2015 , ... Brands like Toppik , Eau Thermale Avene and ... “Before, a threshold of $49.00 was required to qualify for free standard shipping,” said ... standard shipping for customers regardless of the item’s selling price.” , With competitive pricing ...
(Date:8/29/2015)... ... 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops designed for ... unique footage that users can shrink and stretch in the Final Cut Pro X ... customize color, brightness, scale, speed, range, and flare attributes with intuitive controls found in ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... people know that you can use,your heart rate to ... be used,in other ways, too. "Your heart rate can ... system," says Stan Reents, PharmD, a certified personal,trainer, fitness ... increases as exercise intensity increases. By,plugging their age into ...
... A Difference, SEATTLE, Oct. 16 Seattle-based retailer Affirmagy ... make a difference,for women who are newly diagnosed with breast ... so giving is as easy as,clicking a button. "We ... the life of a,woman who has been diagnosed with breast ...
... (NYSE:,VTR) ("Ventas" or the "Company") announced today that it ... close of trading on Thursday,November 8, 2007. A conference ... November 9, 2007 at 10:00 a.m. Eastern Time (9:00 ... CCBN and can be accessed at the,Company,s website at ...
... Missing For #1 Cancer Killer, WASHINGTON, Oct. 15 ... Ambrose said that figures released,earlier today showing an overall ... she warned while the incidence and,mortality rates in lung ... Public health policy officials credited screening as one of ...
... WYE ),confirmed today that it will appeal the ... in the Second Judicial District Court in Reno,Nevada, beginning ... presided over the trial. "This flawed verdict is ... V. Stein, Wyeth,s Senior Vice President and General Counsel.,"The ...
... Sole Source Agreement Supports JHSMH IT Strategy, ... PER ) today said that Jewish Hospital ... based in Louisville, KY, has,selected the company to ... The financial terms of the 10-year agreement were ...
Cached Medicine News:Health News:Exercise And Health: Use Your Heart Rate As a Guide 2Health News:If You Build It, They Will Give 2Health News:Overall Drop in Cancer Death Rate Does Not Apply to Women With Lung Cancer 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 3Health News:Jewish Hospital & St. Mary's Healthcare Select Perot Systems for Technology Services 2Health News:Jewish Hospital & St. Mary's Healthcare Select Perot Systems for Technology Services 3
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
... Utilizing the most complex grinding ... accurate trial lens, are specifically ... quality and precision as the ... marco RT-300 refractor. Marco custom ...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Medicine Products: